{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:20:42Z","timestamp":1792304442295,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ygyno.2012.04.045","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T13:37:19Z","timestamp":1335965839000},"page":"241-244","source":"Crossref","is-referenced-by-count":9,"title":["Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland"],"prefix":"10.1016","volume":"126","author":[{"given":"Virpi","family":"Koskela-Niska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Riska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Lyytinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Pukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Ylikorkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.04.045_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/02841868909111173","article-title":"Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period","volume":"28","author":"Pfeiffer","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0090-8258(89)90051-6","article-title":"Incidence of malignant fallopian tube tumors","volume":"35","author":"Rosenblatt","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.10970","article-title":"Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953\u201397","volume":"104","author":"Riska","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ygyno.2007.09.018","article-title":"The incidence of primary fallopian tube cancer in United States","volume":"107","author":"Stewart","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0025","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/ijc.22491","article-title":"Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975\u20132004","volume":"120","author":"Riska","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0030","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Australian cancer study group. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis","volume":"12","author":"Jordan","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/gyno.1994.1139","article-title":"Prognostic factors in primary fallopian tube carcinoma. Austrian cooperative study group for fallopian tube carcinoma","volume":"53","author":"Rosen","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0040","first-page":"389","article-title":"Clinicopathological features of primary fallopian tube carcinoma: a single institution experience","volume":"30","author":"Papadimitriou","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0045","first-page":"120","article-title":"Immunohistochemical findings in primary fallopian tube cancer. Case report","volume":"31","author":"Raba","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0050","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1634\/theoncologist.11-8-902","article-title":"Fallopian tube carcinoma: a review","volume":"11","author":"Pectasides","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0055","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.ejca.2005.11.041","article-title":"Past chlamydial infection is not associated with primary fallopian tube carcinoma","volume":"42","author":"Riska","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1471-0528.2006.01256.x","article-title":"Human papilloma virus infection and primary fallopian tube carcinoma: a seroepidemiological study","volume":"114","author":"Riska","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2010.03.009","article-title":"Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0070","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol\u2013progestin therapy","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/02841869409098430","article-title":"Data quality and quality control of a population-based cancer registry. Experience in Finland","volume":"33","author":"Teppo","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/140349489402200209","article-title":"Regional variation in surgical procedure rates in Finland","volume":"22","author":"Keskim\u00e4ki","year":"1994","journal-title":"Scand J Soc Med"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0090","series-title":"Modern epidemiology","author":"Rothman","year":"1998"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.ejhg.5200652","article-title":"BRCA1 and BRCA2 mutation among 233 unselected Finnish ovarian carcinoma patients","volume":"9","author":"Sarantaus","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","article-title":"Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients","volume":"92","author":"Syrj\u00e4koski","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0110","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/en.136.5.2110","article-title":"Estrogen induces epidermal growth factor (EGF) receptor and its ligands in human fallopian tube: involvement of EGF but not transforming growth factor-alpha in estrogen-induced tubal cell growth in vitro","volume":"136","author":"Adachi","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0115","article-title":"Combined estrogen\u2013progestogen contraception and combined estrogen\u2013progestogen postmenopausal therapy","volume":"vol. 91","author":"International Agency for Research on Cancer","year":"2003"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0120","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22525","article-title":"Endometrial cancer and menopausal hormone therapy in the National Institutes of Health\u2014AARP diet and healthy study cohort","volume":"109","author":"Lacey","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0125","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/AOG.0b013e3181bea950","article-title":"Endometrial cancer in postmenopausal women using estradiol\u2013progestin therapy","volume":"114","author":"Jaakkola","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results of the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0140","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ijc.23655","article-title":"Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy","volume":"123","author":"Flesch-Janys","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijc.25314","article-title":"Menopausal hormone therapy and breast cancer risk: impact of different treatments","volume":"128","author":"Bakken","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0160","doi-asserted-by":"crossref","DOI":"10.3109\/13697137.2012.663818","article-title":"Ovarian cancer risk in postmenopausal women using estradiol\u2013progestin therapy \u2014 a nationwide study","author":"Koskela-Niska","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0378-5122(99)00027-4","article-title":"Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland","volume":"32","author":"Topo","year":"1999","journal-title":"Maturitas"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0175","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0277-9536(87)90064-5","article-title":"Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms","volume":"24","author":"Rimpel\u00e4","year":"1987","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ygyno.2012.04.045_bb0180","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs","year":"2003"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T03:12:00Z","timestamp":1713928320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0090825812003332"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.04.045","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}